Lijuan Lu

机构：Chinese Academy of Sciences, Guangzhou Institute of Geochemistry, Tongji Hospital, Huazhong University of Science and Technology · ORCID：0000-0002-8465-1024

发表论文 34 篇 · 总被引 678 次 · h-index 13

代表论文

• Engineered triple inhibitory receptor resistance improves anti-tumor CAR-T cell performance via CD56 (2019 · Nature Communications · 被引 123)
• Broadly neutralizing antibody–derived CAR T cells reduce viral reservoir in individuals infected with HIV-1 (2021 · Journal of Clinical Investigation · 被引 105)
• Enhancement of CAR‐T cell activity against cholangiocarcinoma by simultaneous knockdown of six inhibitory membrane proteins (2023 · 癌症：英文版 · 被引 50)
• Nanobody-derived bispecific CAR-T cell therapy enhances the anti-tumor efficacy of T cell lymphoma treatment (2023 · Molecular Therapy — Oncolytics · 被引 35)
• LINC00665 promotes Ovarian Cancer progression through regulating the miRNA-34a-5p/E2F3 axis (2021 · Journal of Cancer · 被引 31)
• Insertion of a solo LTR retrotransposon associates with spur mutations in ‘Red Delicious’ apple (Malus × domestica) (2017 · Plant Cell Reports · 被引 26)